ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01189903
Recruitment Status : Unknown
Verified January 2014 by National University Hospital, Singapore.
Recruitment status was:  Active, not recruiting
First Posted : August 27, 2010
Last Update Posted : January 28, 2014
Sponsor:
Information provided by:
National University Hospital, Singapore